DRUG LIST 7
SYNTHROID
LEVOTHYROXINEClass: T4 Synthetic Hormone
Replacement
IFU: Hypothyroidism
LEVOXYL
LEVOTHYROXINE
Class: T4 Synthetic Hormone Replacement
IFU: Hypothyroidism
GLUCOPHAGE
METFORMIN
Class: Biguanide
IFU: Type 2 Diabetes
ACTOS
PIOGLITAZONE
Class: Thiazolidinedione
IFU: Type 2 Diabetes
AMARYL
GLIMEPIRIDE
Class: Sulfonylurea
IFU: Type 2 Diabetes
DIABETA
GLYBURIDE
Class: Sulfonylurea 2nd Generation
IFU: Type 2 Diabetes
GLUCOTROL
GLIPIZIDE
Class: Sulfonylurea 2nd Generation
IFU: Type 2 Diabetes
JANUVIA
SITAGLIPTIN
Class: Dipeptidyl peptidase- 4 inhibitor
IFU: Type 2 Diabetes
LANTUS
INSULINE GLARGINE
Class: Long Acting Insulin
IFU: Type 1 (Adults and Children) Type 2 (Adults)
NOVOLOG
INSULIN ASPART
Class: Short Acting InsulinIFU: Diabetes –SC
injection, continuous subcutaneous insulin
infusion (SCII), IV infusion
HUMALOG
INSULIN LISPRO
Class: Short Acting Insulin
IFU: Diabetes –SC injection, continuous subcutaneous insulin
infusion pump
FOSAMAX
ALENDRONATE
Class: Bisphosphonate
IFU: Treatment of postmenopausal osteoporosis and
osteoporosis in men
BONIVA
IBANDRONATE
Class: Bisphosphonate
IFU: Prevention and treatment of post-
menopausal osteoporosis
ACTONEL
RISEDRONATEClass: Bisphosphonate
IFU: Prevention and treatment of postmenopausal osteoporosis and
glucocorticoid induced osteoporosis (men & women). Treatment to increase bone
mass in men with osteoporosis. Treatment of Paget’s disease of bone.
YAZ
DROSPIRENONE / ETHINYL ESTRADIOL
Class: Progestin & Estrogen
IFU: Treatment of premenstrual disphoric disorder in women who choose an oral contraceptive as
the method of birth control
ORTHO TRICYCLEN
ETHINYL ESTRADIOL / NORGESTIMATE
Class: Progestin & Estrogen
IFU: Moderate acne vulgaris in females at or older than 15 years of age, who have no
known contraindications to oral contraceptive therapy, desire contraception, have achieved
menarche, and are unresponsive to topical anti-acne medications.
PREMARIN
CONJUGATED ESTROGENS
Class: Estrogen
IFU: Moderate to severe vasomotor symptoms of menopause. Vulvar and
vaginal atrophy. Osteoporosis prevention (consider alternative treatments). Hypoestrogenism
EVISTA
RALOXIFENE HCL
Class: Selective estrogen receptor modulator (SERM)
IFU: Prevention and treatment of osteoporosis in postmenopausal
women
FLOMAX
TAMSULOSIN HCL
Class: Alpha 1A- Blocker
IFU: BPH
PROSCAR
FINASTERIDEClass: Type II 5a- reductase inhibitor
IFU: BPH, to improve symptoms and reduce risks of acute urinary retention
and need for prostate surgery. To reduce risk of symptomatic progression of BPH,
with doxazosin
AVODART
DUTASTERIDEClass: Type I and II 5a- reductase inhibitor
(cGMP-specific)
IFU: BPH, as monotherapy to improve symptoms and reduce risks of acute
urinary retention and need for prostate surgery, or in combination with tamsulosin
VIAGRA
SILDENAFIL CITRATE
Class: Phosphodiesterase type 5 inhibitor (cGMP-
specific)
IFU: Erectile dysfunction
CIALIS
TADALAFIL
Class: Phosphodiesterase type 5 inhibitor (cGMP-
specific)
IFU: Erectile dysfunction
LEVITRA
VARDENAFILClass: Phosphodiesterase type 5
inhibitor (cGMP-specific)
IFU: Erectile dysfunction
ADIPEX
PHENTERMINEClass: Sympathomimetic
IFU: Short-term monotherapy as adjunct. In management of exogenous obesity in
patients with initial body mass at or above 30kg/m2, or at or above 27kg/m2
in presence of other risk factors